All In Biotech

Drug Trial Radar · NCT04974008

Osteosarcoma Maintenance Therapy With OST31-164

An Open-Label Phase 2 Study of Maintenance Therapy With OST31-164 After Resection of Recurrent Osteosarcoma

Last checked: Nov 19, 2026Latest source record: Jan 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

39

Actual

Start

Oct 21, 2021

Primary completion

Sep 21, 2023

Study completion Oct 31, 2027

Sponsor

Lead sponsor
Emerald Clinical Inc.Industry
Sponsor type
Industry
First posted
Jul 22, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 39 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Up to 45 Patients aged 12 to 39 with osteosarcoma (bone cancer) that had recurred in the lungs and has recently been surgically removed will be enrolled. Patients will receive OST31-164 infusions every 3 weeks over 48 weeks and be followed after that for 3 years.

Conditions

  • Bone Cancer

Interventions

  • OST31-164Drug

    Patients who will receive OST31-164 as a single agent every 3 weeks for 48 weeks with 4 doses constituting 1 treatment cycle (12 weeks per cycle). Each patient will receive treatment at a dose of 1x109 CFU until week 48 or until disease progression, unacceptable toxicity, or the patient meets any other treatment discontinuation criteria.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event-Free SurvivalTime frame: Every 3 months, up to one year

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Kaiser Permanente Downey Medical Center

    Los Angeles, California

  • Children's Hospital of Orange County

    Orange, California

  • Rady Children's Hospital

    San Diego, California

  • Children's Hospital of Colorado

    Aurora, Colorado

  • Connecticut Children's

    Hartford, Connecticut

  • Nemours/ Alfred I duPont Hospital for Children

    Wilmington, Delaware

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida

  • Children's Healthcare of Atlanta

    Atlanta, Georgia

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Johns Hopkins Medical Center

    Baltimore, Maryland

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • University of Minnesota/Masonic Cancer Center

    Minneapolis, Minnesota

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Montefiore Medical Center

    The Bronx, New York

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania

  • St. Jude Children's Research Hospital

    Memphis, Tennessee

  • UT Southwestern Medical Center

    Dallas, Texas

  • Seattle Children's Hospital

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.